Sabby Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-14,029
| Closed | -$89K | – | 90 |
|
|
2018
Q2 | $89K | Sell |
14,029
-129,371
| -90% | -$821K | 0.01% | 67 |
|
|
2018
Q1 | $680K | Buy |
+143,400
| New | +$680K | 0.08% | 42 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 100 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 106 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 137 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 152 |
|
|
2016
Q4 | – | Sell |
-87,999
| Closed | -$99K | – | 175 |
|
|
2016
Q3 | $99K | Sell |
87,999
-574,468
| -87% | -$646K | ﹤0.01% | 135 |
|
|
2016
Q2 | $974K | Sell |
662,467
-410,298
| -38% | -$603K | 0.05% | 73 |
|
|
2016
Q1 | $1.53M | Sell |
1,072,765
-13,850
| -1% | -$19.8K | 0.08% | 61 |
|
|
2015
Q4 | $1.78M | Buy |
+1,086,615
| New | +$1.78M | 0.1% | 49 |
|
|
2015
Q1 | – | Sell |
-15,842
| Closed | -$55 | – | 148 |
|
|
2014
Q4 | $55 | Buy |
+15,842
| New | +$55 | ﹤0.01% | 99 |
|